文献リスト

1) Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis: an anthro­pological journey. Am J Pathol. 2008; 173: 1253-64

2) Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proin­flam­matory mediators in cardiovascular disease. Am J Cardiol. 2006; 98: 121-8

3) O'Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromo­some 11. Gene. 1993; 136: 355-60

4) Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998; 251: 471-7

5) Lee DK, Cheng R, Nguyen T, et al. Character­ization of apelin, the ligand for the APJ receptor. J Neurochem. 2000; 74: 34-41

6) Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta. 2001; 1538: 162-71

7) Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endo­thelial cells. Regul Pept. 2004; 118: 119-25

8) Hosoya M, Kawamata Y, Fukusumi S, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem. 2000; 275: 21061-7

9) Jia YX, Pan CS, Zhang J, et al. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept. 2006; 133: 147-54

10) Kleinz MJ, Skepper JN, Davenport AP. Immuno­cytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept. 2005; 126: 233-40

11) Masri B, Lahlou H, Mazarguil H, et al. Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun. 2002; 290: 539-45

12) Hashimoto Y, Ishida J, Yamamoto R, et al. G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility. Int J Mol Med. 2005; 16: 787-92

13) Atluri P, Morine KJ, Liao GP, et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett. 2007; 12: 127-38

14) Ronkainen VP, Ronkainen JJ, Hänninen SL, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J. 2007; 21: 1821-30

15) Sheikh AY, Chun HJ, Glassford AJ, et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol. 2008; 294: H88-98

16) Zhong JC, Yu XY, Huang Y, et al. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res. 2007; 74: 388-95

17) Zhong JC, Huang DY, Liu GF, et al. Effects of all-trans retinoic acid on orphan receptor APJ sig­naling in spontaneously hypertensive rats. Cardiovasc Res. 2005; 65: 743-50

18) Iwanaga Y, Kihara Y, Takenaka H, et al. Down-regulation of cardiac apelin system in hyper­trophied and failing hearts: Possible role of angio­tensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol. 2006; 41: 798-806

19) Kuba K, Zhang L, Imai Y, et al. Impaired heart contractility in Apelin gene-deficient mice asso­ciated with aging and pressure overload. Circ Res. 2007; 101: e32-42

20) Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003; 108: 1432-9

21) Földes G, Horkay F, Szokodi I, et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun. 2003; 308: 480-5

22) Ishida J, Hashimoto T, Hashimoto Y, et al. Re­gulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem. 2004; 279: 26274-9

23) Hashimoto T, Kihara M, Ishida J, et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2006; 26: 1267-72

24) Hashimoto T, Kihara M, Imai N, et al. Re­quirement of Apelin–apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol. 2007; 171: 1705-12

25) Chun HJ, Ali ZA, Kojima Y, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest. 2008; 118: 3343-54

26) Clempus RE, Griendling KK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res. 2006; 71: 216-25

27) Wassmann S, Czech T, van Eickels M, et al. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation. 2004; 110: 3062-7

28) Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology(Bethesda). 2006; 21: 269-80

29) AbdAlla S, Lother H, el Massiery A, et al. Increased AT(1) receptor heterodimers in pre­eclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 2001; 7: 1003-9

30) Leeper NJ, Tedesco MM, Kojima Y, et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol. 2009; 296: H1329-35

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp